 | PharmazieDiese Seite steht derzeit nicht in Ihrer Sprache zur Verfügung. Mittels der
Übersetzungsfunktion
von Google kann Ihnen eine automatische Übersetzung angezeigt werden. Bitte beachten Sie jedoch, dass wir keinerlei Verantwortung für diese
Dienstleistung tragen und die Übersetzung auch nicht von uns geprüft wurde. Raman spectroscopy fulfils a critical analytical role at many stages of the pharmaceutical product design and production process. Applications range from monitoring and controlling large scale manufacturing processes, to profiling the distribution of active pharmaceutical ingredients (API) and excipients at different stages in a formulation cycle.
The illustration shows StreamLine™ Plus chemical images of a pharmaceutical tablet. The image of the complete tablet was collected in 4 minutes, with the image generated from greater than 10,000 individual spectra. The data sets were subsequently analysed using a chemometric technique to identify the three APIs. For more detail on this analysis, and further information on topics related such as high throughput screening (HTS), polymorph discrimination, FDA 21 FDA Part 11 compliance, please download the relevant document. Raman is particularly suited to combining with other analytical techniques given that it provides non-destructive analysis requiring little or no sample preparation, and offers unparalleled polymorph discrimination, is capable of studying aqueous and solid samples. Please note that document downloads require registration. Documents for download
Selected publicationsDefining a strategy for chemical imaging of industrial pharmaceutical samples on Raman line-mapping and global illumination instruments (2006) Donald Clark et al, Applied Spectroscopy, 60, 494-502 Drug characterization in low dosage pharmaceutical tablets using Raman microscopic mapping (2006), Mark J. Henson et al, Applied Spectroscopy, 60, 11, 1247-1255 A comparison of Raman chemical images produced by univariate and multivariate data processing—a simulation with an example from pharmaceutical practice (2004), Slobodan a i et al, Analyst, 129, 1001–1007 Kontaktieren Sie unsBitte kontaktieren Sie uns, wenn Sie weitere Informationen wünschen, eine Preisanfrage haben oder Ihre nationale Renishaw Niederlassung Kontakt zu Ihnen aufnehmen soll. |
